Additionally, inhibition of another histone methyltransferase, G9a, has shown neuroprotective effects in Alzheimer’s disease (AD) models, improving memory and reducing amyloid beta plaques [281]. The gene discussed is PRDM9; the disease is Alzheimer disease.